AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells
2021 · Cell Research · 498 citations
https://doi.org/10.1038/s41422-020-00460-y
W
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
201
Papers
9.5K
Citations
41
h-index
125
i10-index
Wei Xu is an academic researcher from Shanghai Medical College of Fudan University. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & HIV Research and Treatment. The author has an h-index of 41, co-authored 171 publications.
ORCID: 0000-0003-3013-7182Papers by this author
worksRecapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids
2020 · Protein & Cell · 396 citations
https://doi.org/10.1007/s13238-020-00718-6
The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin
2020 · Signal Transduction and Targeted Therapy · 363 citations
https://doi.org/10.1038/s41392-020-0184-0
RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
2020 · Signal Transduction and Targeted Therapy · 205 citations
https://doi.org/10.1038/s41392-020-00402-5
RETRACTED ARTICLE: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion
2020 · Cellular and Molecular Immunology · 172 citations
https://doi.org/10.1038/s41423-020-0424-9
Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide
2021 · Nature Communications · 95 citations
https://doi.org/10.1038/s41467-021-21171-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat